# Direvo Biotech

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/direvo-biotech

- Industry: Biotechnology
- Headquarters: Cologne, Germany
- Website: www.direvo.com
- Total disclosed funding: $45M
- Latest round: Series D (Feb 1, 2010)
- Investors on record: 9

## About

Direvo Biotech is a Germany-based company that operates as a provider of  customized solutions for various industries via the development and optimization of biocatalysts with its proprietary ultra-high-throughput screening platform.

## Funding rounds

- Series D, Feb 1, 2010, $8.5M — TVM Capital Life Science, NRW Bank
- Series C, Oct 18, 2007, $17M — TVM Capital Life Science, Houston Ventures, Bankhaus Wölbern, Signet Healthcare Partners, NRW Bank, Mulligan Biocapital, Danisco Venture, S-Equity Partner
- Series B, Nov 26, 2002, $11M — TVM Capital Life Science, Houston Ventures, SK Capital, Danisco Venture
- Series A, Dec 18, 2000, $8.2M — TVM Capital Life Science, Mulligan Biocapital

## Investors

- TVM Capital Life Science (https://capitalatlas.ai/funds/tvm-capital-life-science) — Series A, Series B, Series C, Series D
- Mulligan Biocapital (https://capitalatlas.ai/funds/mulligan-biocapital) — Series A, Series C
- Houston Ventures (https://capitalatlas.ai/funds/houston-ventures) — Series B, Series C
- SK Capital (https://capitalatlas.ai/funds/sk-capital) — Series B
- Danisco Venture (https://capitalatlas.ai/funds/danisco-venture) — Series B, Series C
- Bankhaus Wölbern — Series C
- Signet Healthcare Partners (https://capitalatlas.ai/funds/signet-healthcare-partners) — Series C
- NRW Bank — Series C, Series D
- S-Equity Partner — Series C